Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium.

[1]  T. Besser,et al.  Expression of Putative Virulence Factors of Escherichia coli O157:H7 Differs in Bovine and Human Infections , 2006, Infection and Immunity.

[2]  S. Wai,et al.  Release of the type I secreted α‐haemolysin via outer membrane vesicles from Escherichia coli , 2006 .

[3]  Vicki Stone,et al.  Carbon black nanoparticles induce type II epithelial cells to release chemotaxins for alveolar macrophages , 2005, Particle and Fibre Toxicology.

[4]  A. Mellmann,et al.  Shiga Toxin 2e-Producing Escherichia coli Isolates from Humans and Pigs Differ in Their Virulence Profiles and Interactions with Intestinal Epithelial Cells , 2005, Applied and Environmental Microbiology.

[5]  A. Mellmann,et al.  Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  H. Karch,et al.  Molecular Profiling and Phenotype Analysis of Escherichia coli O26:H11 and O26:NM: Secular and Geographic Consistency of Enterohemorrhagic and Enteropathogenic Isolates , 2005, Journal of Clinical Microbiology.

[7]  H. Karch,et al.  Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium , 2005, Thrombosis and Haemostasis.

[8]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[9]  H. Karch,et al.  Cytolethal Distending Toxin from Shiga Toxin-Producing Escherichia coli O157 Causes Irreversible G2/M Arrest, Inhibition of Proliferation, and Death of Human Endothelial Cells , 2005, Infection and Immunity.

[10]  A. Friedrich,et al.  A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, in Escherichia coli. , 2004, Molecular nutrition & food research.

[11]  H. Karch,et al.  Characterization of Cytolethal Distending Toxin Genes and Expression in Shiga Toxin-Producing Escherichia coli Strains of Non-O157 Serogroups , 2004, Infection and Immunity.

[12]  Harry L. T. Mobley,et al.  Pathogenic Escherichia coli , 2004, Nature Reviews Microbiology.

[13]  Gilbert S Chen,et al.  Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. , 2003, The Journal of infectious diseases.

[14]  A. Friedrich,et al.  Shiga Toxin 1c-Producing Escherichia coli Strains: Phenotypic and Genetic Characterization and Association with Human Disease , 2003, Journal of Clinical Microbiology.

[15]  H. Karch,et al.  Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11 , 2003, The Pediatric infectious disease journal.

[16]  L. Beutin,et al.  Genetic Diversity of Intimin Genes of Attaching and Effacing Escherichia coli Strains , 2002, Journal of Clinical Microbiology.

[17]  Tatsuo Yamamoto,et al.  Enterohemolysin operon of Shiga toxin‐producing Escherichia coli: a virulence function of inflammatory cytokine production from human monocytes , 2002, FEBS letters.

[18]  L. Trabulsi,et al.  10.321/eid0805.Typical and Atypical Enteropathogenic Escherichia coli , 2002, Emerging infectious diseases.

[19]  H. Karch,et al.  Identification and distribution of the enterohemorrhagic Escherichia coli factor for adherence (efa1) gene in sorbitol-fermenting Escherichia coli O157: H-. , 2002, International journal of medical microbiology : IJMM.

[20]  A. Friedrich,et al.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.

[21]  T. R. Ward,et al.  Iha: a Novel Escherichia coli O157:H7 Adherence-Conferring Molecule Encoded on a Recently Acquired Chromosomal Island of Conserved Structure , 2000, Infection and Immunity.

[22]  U. Fagundes-neto,et al.  A Localized Adherence-Like Pattern as a Second Pattern of Adherence of Classic Enteropathogenic Escherichia coli to HEp-2 Cells That Is Associated with Infantile Diarrhea , 1999, Infection and Immunity.

[23]  F. Gilles,et al.  Selective expression of adhesion molecules on human brain microvascular endothelial cells , 1997, Journal of Neuroimmunology.

[24]  H. Karch,et al.  Enterohemolytic phenotypes and genotypes of shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome , 1996, Journal of clinical microbiology.

[25]  R. Benz,et al.  Pore-forming properties of the plasmid-encoded hemolysin of enterohemorrhagic Escherichia coli O157:H7. , 1996, European journal of biochemistry.

[26]  H. Karch,et al.  Analysis of the EHEC hly operon and its location in the physical map of the large plasmid of enterohaemorrhagic Escherichia coli O157:h7. , 1996, Microbiology.

[27]  R. Welch,et al.  Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7 , 1996, Infection and immunity.

[28]  L. Beutin,et al.  Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933 , 1995, Infection and immunity.

[29]  M. Levine,et al.  A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. , 1987, The Journal of infectious diseases.

[30]  N. Mackman,et al.  Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores , 1986, Infection and immunity.

[31]  H. Lior,et al.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. , 1985, The Journal of infectious diseases.

[32]  J Konowalchuk,et al.  Vero response to a cytotoxin of Escherichia coli , 1977, Infection and immunity.